Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000226203 | SCV000291730 | likely benign | DICER1-related tumor predisposition | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000570173 | SCV000669341 | likely benign | Hereditary cancer-predisposing syndrome | 2023-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001555417 | SCV001776835 | uncertain significance | not provided | 2024-03-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28748527) |
Fulgent Genetics, |
RCV002494670 | SCV002784086 | uncertain significance | Euthyroid goiter; Rhabdomyosarcoma, embryonal, 2; Pleuropulmonary blastoma; Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome | 2021-08-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003469171 | SCV004193324 | uncertain significance | Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome | 2023-10-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004742349 | SCV005349859 | uncertain significance | DICER1-related disorder | 2024-09-12 | no assertion criteria provided | clinical testing | The DICER1 c.920G>A variant is predicted to result in the amino acid substitution p.Arg307His. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0063% of alleles in individuals of African descent in gnomAD. This variant has conflicting interpretations regarding its pathogenicity in ClinVar, ranging from likely benign to uncertain (https://preview.ncbi.nlm.nih.gov/clinvar/variation/242153/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |